Therefore, another explanation for the decreased expression levels may be that TPL testing induced a phase shift (advance) in c-Fos (and pCREB) circadian expression relative to the “normal” expression pattern in HCC mice. The gene discussed is FOS; the disease is hepatocellular carcinoma.